LU73900A1 - - Google Patents

Info

Publication number
LU73900A1
LU73900A1 LU73900A LU73900A LU73900A1 LU 73900 A1 LU73900 A1 LU 73900A1 LU 73900 A LU73900 A LU 73900A LU 73900 A LU73900 A LU 73900A LU 73900 A1 LU73900 A1 LU 73900A1
Authority
LU
Luxembourg
Application number
LU73900A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU73900A1 publication Critical patent/LU73900A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
LU73900A 1974-12-03 1975-12-01 LU73900A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2457047A DE2457047C3 (de) 1974-12-03 1974-12-03 Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe

Publications (1)

Publication Number Publication Date
LU73900A1 true LU73900A1 (cg-RX-API-DMAC10.html) 1976-11-11

Family

ID=5932347

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73900A LU73900A1 (cg-RX-API-DMAC10.html) 1974-12-03 1975-12-01

Country Status (17)

Country Link
US (1) US4029765A (cg-RX-API-DMAC10.html)
JP (1) JPS5182719A (cg-RX-API-DMAC10.html)
AT (1) AT342764B (cg-RX-API-DMAC10.html)
AU (1) AU504575B2 (cg-RX-API-DMAC10.html)
BE (1) BE836228A (cg-RX-API-DMAC10.html)
CA (1) CA1066621A (cg-RX-API-DMAC10.html)
CH (1) CH622701A5 (cg-RX-API-DMAC10.html)
DE (1) DE2457047C3 (cg-RX-API-DMAC10.html)
DK (1) DK544175A (cg-RX-API-DMAC10.html)
ES (1) ES443052A1 (cg-RX-API-DMAC10.html)
FR (1) FR2293217A1 (cg-RX-API-DMAC10.html)
GB (1) GB1531417A (cg-RX-API-DMAC10.html)
IE (1) IE42760B1 (cg-RX-API-DMAC10.html)
IL (1) IL48571A (cg-RX-API-DMAC10.html)
LU (1) LU73900A1 (cg-RX-API-DMAC10.html)
NL (1) NL7513941A (cg-RX-API-DMAC10.html)
SE (1) SE431401B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200627A (en) 1976-07-31 1980-04-29 Behringwerke Aktiengesellschaft Atoxic, immunogenic product of tetanus toxin
US4264588A (en) * 1979-05-10 1981-04-28 The Charles River Breeding Laboratories, Inc. Vaccine for Clostridium perfringens type E enterotoxemia of rabbits
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4594336A (en) * 1982-09-28 1986-06-10 Institut Pasteur Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for obtaining and its application
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US6372225B1 (en) 1996-03-23 2002-04-16 The Research Foundation Of Microbial Diseases Of Osaka University Tetanus toxin functional fragment antigen and tetanus vaccine
ES2237551T3 (es) * 2000-02-08 2005-08-01 Allergan, Inc. Composiciones farmaceuticas que contienen toxina botulinica.
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US20030138460A1 (en) * 2000-02-08 2003-07-24 Allergan, Inc Methods of treating animals with botulinum toxin pharmaceutical compositions
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617344B2 (de) * 1967-05-06 1976-04-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines tetanus-impfstoffes
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs

Also Published As

Publication number Publication date
FR2293217B1 (cg-RX-API-DMAC10.html) 1978-07-28
US4029765A (en) 1977-06-14
DK544175A (da) 1976-06-04
SE7513606L (sv) 1976-06-04
BE836228A (fr) 1976-06-03
ATA915575A (de) 1977-08-15
CH622701A5 (cg-RX-API-DMAC10.html) 1981-04-30
ES443052A1 (es) 1977-07-16
IE42760B1 (en) 1980-10-08
DE2457047B2 (de) 1979-03-15
DE2457047A1 (de) 1976-06-10
IE42760L (en) 1976-06-03
FR2293217A1 (fr) 1976-07-02
GB1531417A (en) 1978-11-08
IL48571A0 (en) 1976-01-30
NL7513941A (nl) 1976-06-08
AU504575B2 (en) 1979-10-18
JPS5182719A (en) 1976-07-20
DE2457047C3 (de) 1979-10-31
AU8716775A (en) 1977-06-09
AT342764B (de) 1978-04-25
CA1066621A (en) 1979-11-20
IL48571A (en) 1980-02-29
SE431401B (sv) 1984-02-06

Similar Documents

Publication Publication Date Title
FR2279067B1 (cg-RX-API-DMAC10.html)
JPS5182719A (cg-RX-API-DMAC10.html)
CS175495B2 (cg-RX-API-DMAC10.html)
CS165715B1 (cg-RX-API-DMAC10.html)
CS178010B1 (cg-RX-API-DMAC10.html)
DE2426935A1 (cg-RX-API-DMAC10.html)
CS170989B1 (cg-RX-API-DMAC10.html)
CS169749B1 (cg-RX-API-DMAC10.html)
CS169717B1 (cg-RX-API-DMAC10.html)
CS173818B1 (cg-RX-API-DMAC10.html)
CS164728B1 (cg-RX-API-DMAC10.html)
CS162423B1 (cg-RX-API-DMAC10.html)
FI266774A7 (cg-RX-API-DMAC10.html)
CS170073B1 (cg-RX-API-DMAC10.html)
CH582339A5 (cg-RX-API-DMAC10.html)
CH611066A5 (cg-RX-API-DMAC10.html)
DD119561A1 (cg-RX-API-DMAC10.html)
CH582876A5 (cg-RX-API-DMAC10.html)
CH588934A5 (cg-RX-API-DMAC10.html)
CH596626A5 (cg-RX-API-DMAC10.html)
BG20483A1 (cg-RX-API-DMAC10.html)
CH591382A5 (cg-RX-API-DMAC10.html)
CH587385A5 (cg-RX-API-DMAC10.html)
CH584454A5 (cg-RX-API-DMAC10.html)
CH598435A5 (cg-RX-API-DMAC10.html)